[Omalizumab. A monoclonal antibody against IgE].
Hennemann
Alexandra
A
Medizinische Monatsschrift für Pharmazeuten, Birkenwaldstr. 44, 70191 Stuttgart. mmp@wissenschaftliche-verlagsgesellschaft.de
D018927:Anti-Asthmatic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000188:drug therapy*; D000075202:Contraindications; D004347:Drug Interactions; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology*; D000069444:Omalizumab
D018927:Anti-Asthmatic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab; D007073:Immunoglobulin E